151 related articles for article (PubMed ID: 19922956)
1. Differential gene expression in chronic inflammatory demyelinating polyneuropathy (CIDP) skin biopsies.
Lee G; Xiang Z; Brannagan TH; Chin RL; Latov N
J Neurol Sci; 2010 Mar; 290(1-2):115-22. PubMed ID: 19922956
[TBL] [Abstract][Full Text] [Related]
2. Gene expression changes in chronic inflammatory demyelinating polyneuropathy skin biopsies.
Puttini S; Panaite PA; Mermod N; Renaud S; Steck AJ; Kuntzer T
J Neuroimmunol; 2014 May; 270(1-2):61-6. PubMed ID: 24657030
[TBL] [Abstract][Full Text] [Related]
3. Parallel expression of neurotrophic factors and their receptors in chronic inflammatory demyelinating polyneuropathy.
Yamamoto M; Ito Y; Mitsuma N; Li M; Hattori N; Sobue G
Muscle Nerve; 2002 Apr; 25(4):601-4. PubMed ID: 11932979
[TBL] [Abstract][Full Text] [Related]
4. Allograft inflammatory factor-1: a pathogenetic factor for vasculitic neuropathy.
Broglio L; Erne B; Tolnay M; Schaeren-Wiemers N; Fuhr P; Steck AJ; Renaud S
Muscle Nerve; 2008 Oct; 38(4):1272-9. PubMed ID: 18816612
[TBL] [Abstract][Full Text] [Related]
5. Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A.
Saporta MA; Katona I; Lewis RA; Masse S; Shy ME; Li J
Brain; 2009 Dec; 132(Pt 12):3263-73. PubMed ID: 19923170
[TBL] [Abstract][Full Text] [Related]
6. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP.
Sommer C; Koch S; Lammens M; Gabreels-Festen A; Stoll G; Toyka KV
Neurology; 2005 Dec; 65(12):1924-9. PubMed ID: 16380614
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological sensory demyelination in typical chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Samarasekera S
Eur J Neurol; 2010 Jul; 17(7):939-44. PubMed ID: 20158514
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.
Dong C; Greathouse KM; Beacham RL; Palladino SP; Helton ES; Ubogu EE
Exp Neurol; 2017 Jun; 292():35-45. PubMed ID: 28215575
[TBL] [Abstract][Full Text] [Related]
9. Sural nerve T-cell receptor Vbeta gene utilization in chronic inflammatory demyelinating polyneuropathy and vasculitic neuropathy.
Bosboom WM; Van den Berg LH; Mollee I; Sasker LD; Jansen J; Wokke JH; Logtenberg T
Neurology; 2001 Jan; 56(1):74-81. PubMed ID: 11148239
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of chronic inflammatory demyelinating polyneuropathy.
Rotta FT; Sussman AT; Bradley WG; Ram Ayyar D; Sharma KR; Shebert RT
J Neurol Sci; 2000 Feb; 173(2):129-39. PubMed ID: 10675657
[TBL] [Abstract][Full Text] [Related]
11. Nerve pathologic features differentiate POEMS syndrome from CIDP.
Piccione EA; Engelstad J; Dyck PJ; Mauermann ML; Dispenzieri A; Dyck PJ
Acta Neuropathol Commun; 2016 Oct; 4(1):116. PubMed ID: 27799073
[TBL] [Abstract][Full Text] [Related]
12. Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy.
Murata K; Dalakas MC
Brain; 2000 Aug; 123 ( Pt 8)():1660-6. PubMed ID: 10908195
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy.
Bosboom WM; van den Berg LH; Franssen H; Giesbergen PC; Flach HZ; van Putten AM; Veldman H; Wokke JH
Brain; 2001 Dec; 124(Pt 12):2427-38. PubMed ID: 11701597
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression in nerve biopsies of inflammatory neuropathies.
Steck AJ; Kinter J; Renaud S
J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():30-3. PubMed ID: 21696494
[TBL] [Abstract][Full Text] [Related]
15. [Biochemical features of chronic inflammatory demyelinating polyradiculoneuropathy].
Antoine JC
Rev Neurol (Paris); 2006 Apr; 162(4):533-8. PubMed ID: 16585917
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound pattern sum score, homogeneity score and regional nerve enlargement index for differentiation of demyelinating inflammatory and hereditary neuropathies.
Grimm A; Vittore D; Schubert V; Lipski C; Heiling B; Décard BF; Axer H
Clin Neurophysiol; 2016 Jul; 127(7):2618-24. PubMed ID: 27291881
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of CIDP in patients with diabetes or CMT1.
Latov N
J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():14-7. PubMed ID: 21696491
[TBL] [Abstract][Full Text] [Related]
18. Charcot-Marie-Tooth disease misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: An international multicentric retrospective study.
Hauw F; Fargeot G; Adams D; Attarian S; Cauquil C; Chanson JB; Créange A; Gendre T; Deiva K; Delmont E; Francou B; Genestet S; Kuntzer T; Latour P; Le Masson G; Magy L; Nardin C; Ochsner F; Sole G; Stojkovic T; Maisonobe T; Tard C; Van den Berghe P; Echaniz-Laguna A
Eur J Neurol; 2021 Sep; 28(9):2846-2854. PubMed ID: 34060689
[TBL] [Abstract][Full Text] [Related]
19. CIDP, CMT1B, or CMT1B plus CIDP?
Cardellini D; Zanette G; Taioli F; Bertolasi L; Ferrari S; Cavallaro T; Fabrizi GM
Neurol Sci; 2021 Mar; 42(3):1127-1130. PubMed ID: 33070202
[TBL] [Abstract][Full Text] [Related]
20. Disease activity in chronic inflammatory demyelinating polyneuropathy: association between circulating B-cell subsets, cytokine levels, and clinical outcomes.
Ozdag Acarli AN; Tuzun E; Sanli E; Koral G; Akbayir E; Cakar A; Sirin NG; Soysal A; Aysal F; Durmus H; Parman Y; Yilmaz V
Clin Exp Immunol; 2024 Jan; 215(1):65-78. PubMed ID: 37638717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
